Entity
  • Kymab Ltd

    Created in 2010
  • BETA

    Probably non active (C)
    Several signals show that this company is not active anymore
  • Social networks

    1,179 9,859
  • Activities

  • Technologies

  • Entity types

  • Location

    The Bennet Building (B930), Babraham Research, Campus, Cambridge CB22 3AT, UK

    Cambridge

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 39

  • Engaged corporates

    4
    1 0
  • Added in Motherbase

    1 year, 9 months ago
Description
  • Value proposition

    Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development.

    Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available.

    Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with best-in-class characteristics quickly and efficiently.

    Advanced Human Antibody Drug Discovery and Development, Drug Discovery, Fully Human Monoclonal Antibodies, and Drug Development

  • Kymab

    Kymab, based in Cambridge, UK, is working independently and with partners to provide novel solutions in drug and vaccine development. Using our unique technology, we rapidly develop broad diversity, high-quality human antibodies for treating challenging diseases. We are building a rich pipeline of assets in four main therapeutic spaces: immuno-oncology, inflammation, haematology and infectious diseases, with clinical studies expected to begin in 2017.

  • http://www.kymab.com
  • Website is disabled or domain is for sale
Corporate interactions BETA
Corporate TypeTweets Articles
Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services
Other

29 Sep 2023


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

27 Mar 2020


Teva Pharmaceuticals
Teva Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Teva Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Mar 2020


London Stock Exchange
London Stock Exchange
Finance, Financial Services
London Stock Exchange
Finance, Financial Services
Other

26 Jan 2017


Similar entities
Loading...
Loading...
Social network dynamics